Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

This study has been completed.

Study NCT00078845 Information provided by M.D. Anderson Cancer Center

First Received on March 8, 2004. Last Updated on October 16, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Breast Cancer
Lung Cancer
Neurotoxicity
Ovarian Cancer
Prostate Cancer

Additional conditions recognized in this trial

Breast Neoplasms
Lung Neoplasms
Neoplasms
Neurotoxicity Syndromes
Ovarian Neoplasms
Peripheral Nervous System Diseases
Prostatic Neoplasms

Interventions listed in this trial

Amifostine

Additional drug interventions recognized in this trial

Paclitaxel

More general drug interventions related to this trial

Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
Tubulin Modulators

Sponsors listed in this trial

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Back to top of Main Content